Bio Essence (BIOE) EBT Margin (2020 - 2026)

Bio Essence's EBT Margin history runs 7 years deep, the most recent figure standing at 43.0% for Q1 2026.

• In Q1 2026, EBT Margin rose 97027.0% year-over-year to 43.0%; the TTM figure through Mar 2026 stood at 55.47% (up 53150.0% YoY), while the FY2025 annual figure was 47.27%, up 53036.0% from the prior year.
• EBT Margin was 43.0% for Q1 2026 at Bio Essence, down from 69.56% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 89.25% in Q4 2023 to a low of 927.27% in Q1 2025.
• Historically, EBT Margin has averaged 151.97% across 5 years, with a median of 41.19% in 2022.
• The sharpest annual moves came in 2025 and 2026: EBT Margin slumped 84734 bps in 2025, then surged 97027 bps in 2026.
• A 5-year view of EBT Margin shows it stood at 41.19% in 2022, then soared by 317 bps to 89.25% in 2023, then sank by 121 bps to 18.68% in 2024, then jumped by 472 bps to 69.56% in 2025, then tumbled by 38 bps to 43.0% in 2026.
• The last three EBT Margin figures came in at 43.0% (Q1 2026), 69.56% (Q4 2025), and 9.5% (Q3 2025), per Business Quant data.